News - Fresenius


Current filters:


Popular Filters

Vifor Fresenius PA21 filed for approval with US FDA, accepted by EMA


A New Drug Application for PA21 (iron(III)-oxyhydroxide) has been submitted to the US Food and Drug Administration.…

EuropeFreseniusGalenicaNephrology and HepatologyNorth AmericaPA21PharmaceuticalRegulationVifor Pharma

Regulatory filing preparations underway for Vifor's PA21 on good Ph III results


The pivotal Phase III clinical study shows that the new phosphate binder PA21 successfully controls hyperphosphatemia…

FreseniusGalenicaNephrology and HepatologyPA21PharmaceuticalRegulationResearchVifor Pharma

Nabi Biopharma gets $5 million milestone under Fresenius accord


In some positive news for US drug developer Nabi Biopharmaceuticals (Nasdaq: NABI), the company said…

FinancialFreseniusLicensingNabi BiopharmaceuticalsPharmaceuticalPhosloPhoslyra

Back to top